HanX

She was born the seventh of nine children in Kuantan. Her father was a public servant who got transferred all over the country, so she grew up moving between small towns. Her mother never finished school. But her mother worked harder than anyone she knew, and believed education was everything. That belief sent Swee Lay Thein to medical school at Universiti Malaya. She graduated in 1975. Then she moved to the UK and spent the next 20 years chasing one stubborn question. Why do some patients with blood disorders suffer terribly, needing transfusions their whole lives, while others barely feel sick? The answer was hidden in a gene. Babies are born producing a special kind of hemoglobin that protects them. Then the body flips a switch and stops making it. Swee Lay wanted to know what controlled that switch. If you could keep it on, you could save millions of lives. It took her decades. She travelled across the UK collecting blood samples from families. She flew to Malawi to study a single family with 270 members across seven generations. She hit dead ends. She kept going. In 2007, she and her team found the gene. They called it BCL11A. That discovery led to Casgevy, the first FDA-approved CRISPR therapy for sickle cell disease and beta-thalassemia. A real cure. Already changing real lives around the world. Last month, Dr Swee Lay Thein stood on a stage in Los Angeles and accepted the Breakthrough Prize, often called the Oscars of Science. She is the first Malaysian-born scientist to ever win it. In her speech she said, "As a child hanging out with my older brothers, playing on old railway tracks in Malaysia, I never imagined being here today." She dedicated the moment to her mother. The woman who never finished school. A girl from Kuantan. A mum who believed in education even though she never got one herself. A daughter whose work is now saving lives around the world. That is a Malaysian story. Tahniah, Dr Swee Lay Thein. We see you. We are proud. 🇲🇾